Dr. Frederick Ch'en

Dr. Frederick Ch'en

Partner, Tokyo

Email frederick.chen@​hoganlovells.com

Phone +81 3 5157 8263

Fax +81 3 5157 8210

LanguagesEnglish, Japanese

Practice groupIntellectual Property

Frederick Ch'en attracts widespread acknowledgement for his outstanding blend of 'strong knowledge about scientific areas' with his patent expertise. Dr Ch'en has impeccable science qualifications including a doctorate in medical sciences which he brings to bear when advising clients on areas of contentious and non-contentious IP, and regulatory regimes.

Chambers Asia-Pacific 2018

For over a decade, Dr. Frederick Ch'en has combined his scientific training and cultural background to advise on a broad range of contentious and non-contentious IP matters, especially in the life sciences area. His particular focus is multi-jurisdictional patent litigation, which also allows him to assist more pragmatically on IP licensing and IP aspects of transactions (e.g., M&A, private equity, and corporate finance).

A former research scientist at Oxford University (with the top First Class Honours degree in Molecular and Cellular Biochemistry (Balliol College) and a doctorate in Medical Sciences (Merton College)), Frederick brings technical insight into clients' disputes or transactions coupled with cross-border perspectives that stem from having been raised in four different cultures.

Frederick is a solicitor (England & Wales), U.S. attorney (California), U.S. patent attorney, a registered foreign attorney in Japan, and a U.K. chartered biologist. He has been recognised as a leading practitioner by various publications, including Chambers Asia, Legal 500, and MIP. Chambers Asia calls him "an exceptional IP specialist" and "meticulous, responsive, and comfortable working on complex matters in multiple jurisdictions," and Legal 500 Asia Pacific an "excellent advisor," "responsive and experienced," "diligent and talented," and someone who "can easily understand the technical issues and is very good at figuring out a solution."

Prior to joining Hogan Lovells, Frederick was head of IP in the Tokyo office of another top-tier law firm (2010-2013), having initially trained and worked for seven years in the London office of a top-tier "Magic Circle" international law firm. He is a member of AIPPI Japan, the Licensing Executive Society in Japan, and Pharma Delegates. Frederick speaks English and Japanese.

Awards and recognitions

2017-2018

Sole winner of Client Choice Award for Patents in Japan
International Law Office

2012-2018

Leading individual for Intellectual Property in Japan
Chambers Asia-Pacific

2014-2018

Leading individual for Intellectual Property in Japan
Chambers Global

2018

Leading individual for Life Sciences in Japan
Chambers Asia-Pacific

2018

Global IP Star
Managing Intellectual Property IP Stars

2014-2017

IP Stars for Patents in Japan
Managing Intellectual Property

2017

Leading individual for Patent Transaction and Patent Litigation in Japan
IAM Patent 1000

2015-2019

Listed in Best Lawyers in Japan

2017

Leading individual in IP Litigation
Who's Who Legal Japan

2017-2018

World IP Review Leader

Education and admissions

Education

Pg.D.I.P.L.P. (Intellectual Property Law & Practice), University of Bristol, 2006

Pg.D.L.P. (Legal Practice), distinction, Oxford Institute of Legal Practice, 2002

D.Phil. (Medical Sciences), University of Oxford, Merton College, 2001

Pg.D.L. (Law), distinction, Oxford Brookes University, 2001

M.Biochem. (Molecular and Cellular Biochemistry), First Class Honours, University of Oxford, Balliol College, 1997

Memberships

Member and Editorial Board Member, AIPPI (Japan)

Member, Licensing Executive Society (Japan)

Member, Pharma Delegates (Japan)

Member and Chartered Biologist, Royal Society of Biology (UK)

Member, Biochemical Society (UK)

Bar admissions and qualifications

England and Wales

California

U.S. Patent and Trademark Office

Japan - Daiichi Tokyo Bar Association (Gaikokuho Jimu Bengoshi)

Court admissions

Senior Courts of England and Wales

Representative experience

Acting for various global originator pharmaceutical companies in relation to numerous patent disputes in Japan, including patent invalidation actions before the Japanese Patent Office, appeals before the IP High Court and patent infringement proceedings (as claimant and defendant) before the Tokyo District Court in conjunction with Japanese bengoshi lawyers

Acting for a Japanese pharmaceutical company in relation to its European strategy for filing Supplementary Protection Certificates in 26 countries

Acting for a Japanese pharmaceutical company in relation to regulatory data exclusivity in Europe and the U.S.

Acting for a Japanese pharmaceutical company in relation to patent infringement proceedings against three generic companies in Hong Kong

Acting for a Japanese life sciences company in relation to contract negotiations with a U.S. counterparty

Acting for a Japanese life sciences company in relation to a patent licence from a U.S. counterparty

Acting for a Japanese engineering company in relation to its licensing negotiations with a European university in respect of joint research, development and exploitation

Acting for a Japanese electronics company in relation UK patent litigation proceedings

Acting for a Japanese technology company in relation to its global trademark and brand licensing

Acting for a European pharmaceutical company in relation to the assignment and licence-back of certain patents from a Japanese pharmaceutical company in the context of its multi-million US dollar acquisition by a U.S. pharmaceutical company

Acting for Merck & Co., Inc. in relation to defending patent revocation proceedings in relation to its enzyme inhibitor product (finasteride), a ground-breaking case that changed the English law on the patentability of dosing regimens and the rules of precedent in the UK Court of Appeal

Latest thinking and events

Hogan Lovells Events

Going Global

Events

Tokyo workshop series on practical and strategic considerations for the forthcoming Unitary Patent ("UP") /Unitary Patent Court ("UPC") system for Japanese life sciences and technology companies

Loading data